The methodology described herein details a protocol to genetically ablate the retinal pigment epithelium (RPE) utilizing larval zebrafish. The RPE extends over the back of the eye and resides between the stratified layers of the neural retina and the layer of vasculature constituting the choroid. Trophic support, absorption of phototoxic light, and maintenance of visual cycle proteins are only some of the critical functions the RPE performs that are essential for sustaining the health and integrity of these adjacent tissues1. Damage to mammalian RPE is reparable when lesions are small2; however, damage suffered by larger injuries or progressive degenerative disease is irreversible. In humans, RPE degenerative diseases (e.g., age-related macular degeneration (AMD) and Stargardt disease) lead to permanent vision loss and, with few treatment options available, decreased patient quality of life. The limited ability for mammalian RPE to self-repair has created a knowledge gap in the field of RPE regenerative processes. Given the robust regenerative capacity of the zebrafish across many different tissue types, this protocol was developed to establish an in vivo vertebrate system to facilitate studies on intrinsically regenerating RPE and uncover mechanisms that drive that response. Using the ablation paradigm outlined here, the canonical Wnt signaling pathway3, the mTOR pathway4, and immune-related responses5 have been identified as critical mediators of RPE regeneration, likely with overlapping functions.
In this genetic ablation paradigm, Tg(rpe65a:nfsB-eGFP)3 zebrafish express the bacterial-derived nitroreductase (NTR/nfsB) gene6 fused to eGFP under control of the RPE enhancer element, rpe65a7. Ablation is achieved by adding the prodrug, metronidazole (MTZ), to system water housing zebrafish. Intracellular activation of MTZ by nitroreductase results in DNA crosslinking and apoptosis in NTR/nfsB-expressing cells8,9. This technology has been widely used in zebrafish to ablate cells of the retina10,11,12,13 and other tissues8. Together, these elements enable targeted expression (rpe65a) of an inducible cell ablation methodology (NTR/MTZ)8,9 and a fluorescent marker (eGFP) for visualization.
Other interesting in vivo models also exist that can be used to study the regenerative potential of the RPE14. These are broad and include RPE-to-retina transdifferentiation post-retinectomy in amphibians, in which RPE cells lost to retinal regrowth are replaced15,16; RPE restoration post-injury in the "super healing" MRL/MpJ mouse17; and exogenous stimulation of RPE proliferation in a rat model of spontaneous RPE and retinal degeneration18, among others. In vitro models, such as adult human RPE stem cells (RPESCs)19 have also been developed. These models are all valuable tools working to uncover the cellular processes related to RPE regeneration (e.g., proliferation, differentiation, etc.); however, the zebrafish is unique in its capacity for intrinsic RPE repair post-ablation.
While the methodology here is written to focus on understanding the mechanisms driving RPE regeneration, the Tg(rpe65a:nfsB-eGFP) line and this genetic ablation protocol could be utilized to study other cellular processes such as RPE apoptosis, RPE degeneration, and the effect of RPE injury on adjacent retinal and vascular tissues. The ablation protocol can also be modified to include pharmacological manipulation, which is a convenient preliminary strategy to screen signaling pathways of interest. For example, blocking the canonical Wnt pathway using Inhibitor of Wnt Response-1 (IWR-1)20, has been shown to impair RPE regeneration3. This was repeated here to guide users through a pharmacological manipulation experiment and serve as proof-of-concept to validate a MATLAB script (RpEGEN) created to quantify RPE regeneration based on recovery of pigmentation. Like the transgenic line and ablation protocol, the RpEGEN scripts are adaptable and could be used to quantify other markers/cellular processes within the RPE.